HULL HANS (Chief Business Officer) sold 4.2% of their position (9.90K shares) of PLIANT THERAPEUTICS, INC. on the open market
Open‑market sale worth $114.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/12/2024ACC: 0001746473-24-000127
Officer· Chief Business Officer
Since Jun 2020
-9.90K
Net shares
Net seller
$114.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.90K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.90K
Price / share
$11.56
Trade value
$114.44K
% of position
4.2%
7/10/2024
237.39K→227.49K
Total
Net shares
−9.90K
Net value
-$114.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2024 | S · Sale | −9.90K | $11.56 | $114.44K | 4.2% | 237.39K | 227.49K |
| Total | −9.90K | -$114.44K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned3.82K
Common Stock
IndirectShares owned13.98K
Common Stock
IndirectShares owned13.98K
Total
31.79K indirect31.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.82K | Indirect |
| Common Stock | 13.98K | Indirect |
| Common Stock | 13.98K | Indirect |
| Total | 31.79K | 31.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported